Medtronic plc (LON:0Y6X)
97.58
-2.01 (-2.02%)
At close: Jan 9, 2026
Medtronic Revenue
Medtronic had revenue of $8.96B USD in the quarter ending October 24, 2025, with 6.64% growth. This brings the company's revenue in the last twelve months to $34.76B, up 5.34% year-over-year. In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth.
Revenue (ttm)
$34.76B
Revenue Growth
+5.34%
P/S Ratio
3.57
Revenue / Employee
$365.87K
Employees
95,000
Market Cap
93.27B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
| Apr 26, 2019 | 30.56B | 604.00M | 2.02% |
| Apr 27, 2018 | 29.95B | 243.00M | 0.82% |
| Apr 28, 2017 | 29.71B | 877.00M | 3.04% |
| Apr 29, 2016 | 28.83B | 8.57B | 42.31% |
| Apr 24, 2015 | 20.26B | 3.26B | 19.15% |
| Apr 25, 2014 | 17.01B | 415.00M | 2.50% |
| Apr 23, 2013 | 16.59B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Medtronic News
- 1 day ago - MDT: Bernstein Raises Price Target for Medtronic | MDT Stock News - GuruFocus
- 1 day ago - Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 - The Motley Fool
- 2 days ago - Barclays Raises Price Target for Medtronic (MDT) to $116 | MDT Stock News - GuruFocus
- 4 days ago - Why Is Medtronic Stock Trading Higher After Analyst Upgrade - Benzinga
- 4 days ago - Why Is Medtronic Stock Trading Higher After Analyst Upgrade - Benzinga
- 4 days ago - Medtronic (MDT) Upgraded to Outperform by William Blair | MDT Stock News - GuruFocus
- 5 days ago - The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson - Nasdaq
- 5 days ago - Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - PRNewsWire